Sharekhan

Kokuyo Camlin Ltd

Fri 18/07/2025,15:59:51 | NSE : KOKUYOCMLN

₹ 118.97-0.68 (-0.57%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 119.65

Previous Close

₹ 119.65

Volume

103762

Mkt Cap ( Rs. Cr)

₹1193.31

High

₹ 120.13

Low

₹ 117.51

52 Week High

₹ 230.89

52 Week Low

₹ 95.63

Book Value Per Share

₹ 29.61

Dividend Yield

0.00

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Kokuyo Camlin Ltd

Your Vote -

Buy

35.29%

Hold

17.65%

Sell

47.06%

35.29%

34 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

58%

Sell Order Quantity

42%

Bid Price

Qty

118.56

1087

119.00

42

118.00

3

118.00

152

118.00

40

Bid Total

75393

Bid Price

Qty

119.02

266

119.00

255

119.00

3

119.00

3

119.00

3

Bid Total

54484

Option Chain

Analyzes market sentiment, predicts Kokuyo Camlin Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Kokuyo Camlin has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    19 Jul 2025, 7:02AM As of June 2025, 74.99% is owned by Promoters and 25.01% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 0.55% and Foreig
  • Kokuyo Camlin - Updates

    16 Jul 2025, 3:26PM Kokuyo Camlin Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018' for the quarter ended on
  • Kokuyo Camlin - Certificate Under Regulation 74(5) Of SEBI (DP) Regulations, 2018

    16 Jul 2025, 3:08PM Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on 30th June, 2025
  • Kokuyo Camlin - General Updates

    15 Jul 2025, 2:42PM Kokuyo Camlin Limited has informed the Exchange about letter sent to shareholders for annual report 2024-25
  • Kokuyo Camlin - Copy of Newspaper Publication

    15 Jul 2025, 2:34PM Kokuyo Camlin Limited has informed the Exchange about Copy of Newspaper Publication regarding 78th Annual General Meeting of the Company
  • Kokuyo Camlin - Letter Sent To Shareholders

    15 Jul 2025, 2:28PM Letter sent to shareholders_ Annual report _ 2024-25
  • Kokuyo Camlin - Updates

    14 Jul 2025, 8:31PM Kokuyo Camlin Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report 2024-25'.
  • Kokuyo Camlin - Notice Of Shareholders Meetings-XBRL

    14 Jul 2025, 6:36PM KOKUYO CAMLIN LIMITED has informed the Exchange about Notice of Shareholders Meeting for Annual General Meeting to be held on 08-Aug-2025
  • Kokuyo Camlin - Shareholders meeting

    14 Jul 2025, 6:24PM Kokuyo Camlin Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 08, 2025
  • Kokuyo Camlin - Business Responsibility and Sustainability Reporting (BRSR)

    14 Jul 2025, 5:55PM Business Responsibility and Sustainability Report for the financial year ended on 31st March, 2025.
  • Kokuyo Camlin - Notice Of 78Th Annual General Meeting

    14 Jul 2025, 5:50PM Notice of 78th Annual General Meeting
  • Kokuyo Camlin - Reg. 34 (1) Annual Report.

    14 Jul 2025, 5:43PM Annual Report for the financial year 2024-2025
  • Kokuyo Camlin - Copy of Newspaper Publication

    9 Jul 2025, 12:01PM Kokuyo Camlin Limited has informed the Exchange about Copy of Newspaper Publication regarding 78th Annual General Meeting
  • Kokuyo Camlin - Disclosure under SEBI Takeover Regulations

    3 Jul 2025, 10:34PM ÿShriram Dandekarÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial
  • Kokuyo Camlin - Disclosure under SEBI Takeover Regulations

    3 Jul 2025, 7:28PM Dilip D. Dandekar has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial
  • Kokuyo Camlin - Disclosure under SEBI Takeover Regulations

    1 Jul 2025, 3:49PM KOKUYO Co., Ltd. has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial
  • Kokuyo Camlin - Trading Window-XBRL

    26 Jun 2025, 3:17PM KOKUYO CAMLIN LIMITED has informed the Exchange about Closure of Trading Window
  • Kokuyo Camlin - Trading Window

    26 Jun 2025, 3:15PM Kokuyo Camlin Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 20
  • Kokuyo Camlin - Spurt in Volume

    11 Jun 2025, 10:49AM Significant increase in volume has been observed in Kokuyo Camlin Limited. The Exchange, in order to ensure that investors have latest relevant inform
  • Kokuyo Camlin - Spurt in Volume

    10 Jun 2025, 6:45PM Significant increase in volume has been observed in Kokuyo Camlin Limited. The Exchange, in order to ensure that investors have latest relevant inform
  • Kokuyo Camlin - Outcome of Board Meeting-XBRL

    30 May 2025, 11:55AM KOKUYO CAMLIN LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 28-May-2025 for Dividend
  • Kokuyo Camlin - Copy of Newspaper Publication

    30 May 2025, 11:18AM Kokuyo Camlin Limited has informed the Exchange about Copy of Newspaper Publication for the audited financial results for the fourth quarter/ year end
  • Kokuyo Camlin - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    29 May 2025, 12:16PM KOKUYO CAMLIN LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
  • Kokuyo Camlin - Updates

    28 May 2025, 10:29PM Kokuyo Camlin Limited has informed the Exchange regarding 'Book closure for 78th AGM'.
  • Kokuyo Camlin - Book Closure For 78Th Annual General Meeting

    28 May 2025, 10:23PM Book Closure for 78th Annual General meeting
  • Kokuyo Camlin Q4 net profit down 57.87% at Rs 4.39 cr

    28 May 2025, 9:33PM The company reported standalone net profit of Rs 4.39 crore for the quarter ended March 31, 2025 as compared to Rs 10.42 crore in the same period last
  • Kokuyo Camlin - Outcome of Board Meeting

    28 May 2025, 9:30PM Kokuyo Camlin Limited has informed the Exchange regarding outcome of the Board meeting held on May 28, 2025.
  • Kokuyo Camlin - Board Meeting Outcome for Outcome Of The Board Meeting Held On 28Th May, 2025

    28 May 2025, 9:27PM Outcome of the Board meeting held on 28th May, 2025
  • Kokuyo Camlin - Outcome of Board Meeting

    28 May 2025, 9:15PM Kokuyo Camlin Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
  • Kokuyo Camlin - Audited Financial Results For The Quarter / Year Ended On 31St March, 2025

    28 May 2025, 9:01PM Audited financial results for the quarter/year ended on 31st March, 2025
  • Kokuyo Camlin - Board Meeting Intimation

    21 May 2025, 4:22PM KOKUYO CAMLIN LIMITED has informed the Exchange about Board Meeting to be held on 28-May-2025 to consider and approve the Yearly Audited Financial res
  • Kokuyo Camlin - Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results For The Quarter And

    21 May 2025, 4:14PM Kokuyo Camlin Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to consider and a
  • Kokuyo Camlin has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    21 Apr 2025, 5:50PM As of March 2025, 74.99% is owned by Promoters and 25.01% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 0.55% and Forei

Key fundamentals

Evaluate the intrinsic value of Kokuyo Camlin Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 343.5602 361.407 318.3831 309.8724 314.0671
Liabilities 343.5602 361.407 318.3831 309.8724 314.0671
Equity 10.0304 10.0304 10.0304 10.0304 10.0304
Gross Profit 33.8185 76.5889 54.3681 16.5077 8.8433
Net Profit 5.833 43.832 24.4473 -4.7285 -14.6184
Cash From Operating Activities 54.5355 18.8354 27.4786 17.8029 61.7598
NPM(%) 0.76 5.37 3.15 -0.92 -3.62
Revenue 762.5288 815.8933 774.9432 508.4723 403.1237
Expenses 728.7103 739.3044 720.5751 491.9646 394.2804
ROE(%) 1.96 14.75 8.23 -1.59 -4.92

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
30 Jul 2024 0.5 50 0 166.9
21 Jul 2023 0.5 50 0 77.5
29 Jun 2011 0.25 25 0 79.7
21 Jun 2010 0.5 50 0 28
18 Jun 2009 0.3 30 0 11.4

Peers

Other companies within the same industry or sector that are comparable to Kokuyo Camlin Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Inox Green Energy Services Ltd 163.70 3.71 308.87 3505.66 5.40 0.00
Prozone Realty Ltd 38.62 -3.69 0.00 1822.08 -124.26 0.00
Sahyadri Industries Ltd 308.45 0.87 17.36 130.74 177.78 0.32
Jindal Photo Ltd 897.85 2.00 4.08 122.48 2202.55 0.00

Company Info

YEAR EVENTS 1946 - The Company was incorporated on 24th December, as a private limited company with the main object of taking over the running business of M/s. Dandekar & Co., which was founded by late G.P. Dandekar and D.P. Dandekar in 1931 at Girgaum, Mumbai. The Company manufacture stationary products, art materials and pharmaceuticals. The Company was converted into a public limited company on 24th March, 1988 and the name was changed to Camlin Ltd. - The initial product range of M/s. Dandekar & Co., comprised of ink tablets, fountainpen ink, office adhesives, sealing wax, school chalks, brilliantine, pain balm, etc. which took part in business activities in 1939 and was shifted to Mahim, Mumbai. 1964 - The Company embarked on the first diversification of products by producing for the first time in India, the complete range of artist colours and materials such as water colours, poster colours, oil colours, fabric colours, geometry boxes, drawing inks, painting brushes and canvases. Many products were also added subsequently. 1974 - The production of wood cased pencils was taken up in the fully integrated plant in the industrially backward area of Tarapur, Maharashtra. 1978 - In December 1947, 600 shares issued without payment in cash to vendores as part consideration for taking over their business. Till date, 32,250 shares were issued as bonus shares by capitalisation of reserves (2,250 shares in Dec. 1966 in prop. 1:2; 10,000 shares in March 1975 in prop. 1:1 and 20,000 shares in April in prop. 1:1. 1981 - As on 31st December, the company was holding 6,00,000 fully paid up equity shares of M.$ 1 each. 1982 - A joint venture company "Camlin N.S. Sdn. Bhd" set up in Malaysia was closed down with effect from 28th February, following a directive from the Malaysian Government in line with its decision to order closure of operations of all the joint venture companies which were incurring losses over the past many years. - After obtaining necessary approvals from the Ministry of Commerce Government of India, the Company divested its entire shareholding amounting to M $ 6,80,000. 1984 - The Company took a major step forward by diversifying its manufacturing and marketing activity into the field of pharmaceuticals, ie., bulk drugs and formulations at Tarapur. - The Company acquired a licence to manufacture 42.100 tonnes per annum of bulk drugs such as Diloxanide Fuorate, Mebendzole, Diazepam and Ibuprofen. A plant at Tarapur was set up with an installed capacity of 15,400 tonnes per annum. 1986 - Workers of the pencil factory at Tarapur went on strike with effect from 10th March. The operations were restarted only on 19th October after signing an agreement with the Labour Union valid upto 31st March, 1989. 1987 - The Company decided to set up a plant at Tarapur for the manufacture of Hi-Polymer Lead. A technical know-how agreement valid for a period of 5 years was concluded in November/December with Pilot Pen Co. Ltd., of Japan. - In April, 3,200 No. of equity shares of Rs.100 each issued at par Equity shares then sub-divided. 4,32,000 bonus equity shares of Rs.10 each issued in prop. 1:1 in October 1987. 1988 - The Company's products are marketed under the brand names of "Camel" and "Camlin". Its Analytical Laboratory at Andheri is recognised as a public testing house by State Food & Drug Administration of Maharashtra and the R & D laboratory is aproved by the Department of Scientific and Industrial Research, Government of India. - During June, some of the then existing shareholders of the Company offered for sale 3,00,000 equity shares of Rs.10 each at a premium of Rs.20 per share to enable the Company to list its shares on the recognised Stock Exchanges. Out of the total shares offered for sale, 15,000 shares were reserved and allotted on a preferential basis to the employees (including Indian working directors) of the Company. The balance 2,85,000 shares were offered for sale to the public (all were taken up). - During June, the company offered 1,00,000-14% secured redeemable convertible debentures of Rs.240 each for cash at par. Out of which, 5,000 debentures were reserved for preferential allotment to employees/Indian working directors/workers of the Company (only 2,050 debentures taken up) and 11,000 debentures were reserved for allotment of UTI on firm basis. The remaining 84,000 debentures, along with the unsubscribed 2,950 debentures of employees quota were offered for public subscription. All the debentures were taken up. 150 debentures were forfeited during 1989-90. - Each debenture consists of a convertible portion of Rs.140 and a non-convertible portion of Rs.100. At the end of six months from the date of allotment of debentures, Rs.140 of each debenture was automatically and compulsorily converted into 5 equity shares of Rs.10 each at a premium of Rs.18 per share. The non-convertible portion of Rs.100 of each debenture shall be redeemed at par in three equal instalments at the end of 7th, 8th and 9th year from the date of their allotment by drawing three equal lots. - 96,000 shares issued at par in March 1988. 4,80,000 bonus shares issued in June 1988 in prop. 1:2 to shareholders prior to the offer for sale to the public. 4,97,550 shares allotted (prem. Rs.18 per share) in conversion of debentures. 1989 - 1,700 shares were allotted (prem. Rs.18 per share) in conversion of debs. 1990 - 750 shares issued in conversion of debs. (prem. Rs.18 per share). 1991 - As at 31st March, 1991, the Company revalued its land and buildings and the net surplus of Rs.330.26 lakhs arising out of it was credited to the revaluation reserve. 1994 - The Company entered into a marketing alliance with Colart Fine Art & Graphics Ltd. U.K. - The Company embarked upon a project for expanding manufacturing capacities of existing bulk drugs/chemical plant at Tarapur. - The Company undertook to set up a facility for manufacture of industrial grade synthetic adhesives at Taloja near Mumbai. - The Company issued Warrants to promoter group on preferential allotment basis. Of the 4,60,000 warrants, 3,32,000 warrants were converted into equity shares. - 3,32,100 equity shares allotted in conversion of warrants. 1995 - A major fire broke at Tarapur factory due to suspected electrical short circuit which led to destruction of godown, raw materials etc. - The Company initiated measures such as introduction of new products, change in product-mix, reduction in overheads and thrust on higher value addition. - 71,900 No. of Equity shares allotted in conversion of warrants. 1996 - 56,000 No. of Equity shares allotted in conversion of warrants. 1997 - The Joint Venture Agreement with M/s. A. W. Faber-Castell Gmbh & Co. Germany was terminated by both parties with effect from 30th November. - The company redeemed the last instalment of 33,340-14% Secured Redeemable Non-Convertible Debentures of Rs 100/- each issued in the year 1988. 2002 -Camlin Ltd has informed that Mr S D Dandekar, Executive Chairman of the Company, will be retiring from the Chairmanship of the Company. Mr D D Dandekar, Managing Director of the Company will be redesignated as "Chairman and Managing Director" w e f June 01, 2002. 2004 -Camlin Pharma, a division of Camlin Ltd, launched its mosquito repellent body spray, Repelmos, in the southern states -Delist from The Delhi Stock Exchange Association Ltd (DSE) with effect from December 11, 2004. 2005 -Camlin - JV with ColArt Fine Art & Graphics, U.K 2008 - The Company has splits its face value from Rs10/- to Rs1/-. 2011 -The Company have appointed M/s. Bigshare Services Private Limited having office at E/2,, Ansa Industrial Estate, Saki-Vihar Road, Sakinaka, Andheri (E), Mumbai - 400072 as Company's Registrar and Transfer Agents for the Company. 2012 -Company has changed its name from Camlin Ltd. to Kokuyo Camlin Ltd. 2013 -Kokuyo Camlin Ltd has ecided to issue Equity Shares on right basis in the ratio of 14 Equity Shares for every 29 Equity Shares held in the Company, of face value of Re. 1/- per Equity Share -Kokuyo Camlin Ltd has informed that the Company has received Rs. 10323.66 Lacs by way of allotment of Equity Shares on Rights basis. -Kokuyo Camlin has given Rights in the Ratio of 14 : 29 2014 -Directors has approved the appointment of Mr. Venkataraman Sriram as a Director. 2015 - Kokuyo Camlin to build state-of-the-art factory in Maharashtra. 2017 -Company has has started its Commercial Production/supply on 28th April, 2017

YEAR EVENTS 1946 - The Company was incorporated on 24th December, as a private limited company with the main object of taking over the running business of M/s. Dandekar & Co., which was founded by late G.P. Dandekar and D.P. Dandekar in 1931 at Girgaum, Mumbai. The Company manufacture stationary products, art materials and pharmaceuticals. The Company was converted into a public limited company on 24th March, 1988 and the name was changed to Camlin Ltd. - The initial product range of M/s. Dandekar & Co., comprised of ink tablets, fountainpen ink, office adhesives, sealing wax, school chalks, brilliantine, pain balm, etc. which took part in business activities in 1939 and was shifted to Mahim, Mumbai. 1964 - The Company embarked on the first diversification of products by producing for the first time in India, the complete range of artist colours and materials such as water colours, poster colours, oil colours, fabric colours, geometry boxes, drawing inks, painting brushes and canvases. Many products were also added subsequently. 1974 - The production of wood cased pencils was taken up in the fully integrated plant in the industrially backward area of Tarapur, Maharashtra. 1978 - In December 1947, 600 shares issued without payment in cash to vendores as part consideration for taking over their business. Till date, 32,250 shares were issued as bonus shares by capitalisation of reserves (2,250 shares in Dec. 1966 in prop. 1:2; 10,000 shares in March 1975 in prop. 1:1 and 20,000 shares in April in prop. 1:1. 1981 - As on 31st December, the company was holding 6,00,000 fully paid up equity shares of M.$ 1 each. 1982 - A joint venture company "Camlin N.S. Sdn. Bhd" set up in Malaysia was closed down with effect from 28th February, following a directive from the Malaysian Government in line with its decision to order closure of operations of all the joint venture companies which were incurring losses over the past many years. - After obtaining necessary approvals from the Ministry of Commerce Government of India, the Company divested its entire shareholding amounting to M $ 6,80,000. 1984 - The Company took a major step forward by diversifying its manufacturing and marketing activity into the field of pharmaceuticals, ie., bulk drugs and formulations at Tarapur. - The Company acquired a licence to manufacture 42.100 tonnes per annum of bulk drugs such as Diloxanide Fuorate, Mebendzole, Diazepam and Ibuprofen. A plant at Tarapur was set up with an installed capacity of 15,400 tonnes per annum. 1986 - Workers of the pencil factory at Tarapur went on strike with effect from 10th March. The operations were restarted only on 19th October after signing an agreement with the Labour Union valid upto 31st March, 1989. 1987 - The Company decided to set up a plant at Tarapur for the manufacture of Hi-Polymer Lead. A technical know-how agreement valid for a period of 5 years was concluded in November/December with Pilot Pen Co. Ltd., of Japan. - In April, 3,200 No. of equity shares of Rs.100 each issued at par Equity shares then sub-divided. 4,32,000 bonus equity shares of Rs.10 each issued in prop. 1:1 in October 1987. 1988 - The Company's products are marketed under the brand names of "Camel" and "Camlin". Its Analytical Laboratory at Andheri is recognised as a public testing house by State Food & Drug Administration of Maharashtra and the R & D laboratory is aproved by the Department of Scientific and Industrial Research, Government of India. - During June, some of the then existing shareholders of the Company offered for sale 3,00,000 equity shares of Rs.10 each at a premium of Rs.20 per share to enable the Company to list its shares on the recognised Stock Exchanges. Out of the total shares offered for sale, 15,000 shares were reserved and allotted on a preferential basis to the employees (including Indian working directors) of the Company. The balance 2,85,000 shares were offered for sale to the public (all were taken up). - During June, the company offered 1,00,000-14% secured redeemable convertible debentures of Rs.240 each for cash at par. Out of which, 5,000 debentures were reserved for preferential allotment to employees/Indian working directors/workers of the Company (only 2,050 debentures taken up) and 11,000 debentures were reserved for allotment of UTI on firm basis. The remaining 84,000 debentures, along with the unsubscribed 2,950 debentures of employees quota were offered for public subscription. All the debentures were taken up. 150 debentures were forfeited during 1989-90. - Each debenture consists of a convertible portion of Rs.140 and a non-convertible portion of Rs.100. At the end of six months from the date of allotment of debentures, Rs.140 of each debenture was automatically and compulsorily converted into 5 equity shares of Rs.10 each at a premium of Rs.18 per share. The non-convertible portion of Rs.100 of each debenture shall be redeemed at par in three equal instalments at the end of 7th, 8th and 9th year from the date of their allotment by drawing three equal lots. - 96,000 shares issued at par in March 1988. 4,80,000 bonus shares issued in June 1988 in prop. 1:2 to shareholders prior to the offer for sale to the public. 4,97,550 shares allotted (prem. Rs.18 per share) in conversion of debentures. 1989 - 1,700 shares were allotted (prem. Rs.18 per share) in conversion of debs. 1990 - 750 shares issued in conversion of debs. (prem. Rs.18 per share). 1991 - As at 31st March, 1991, the Company revalued its land and buildings and the net surplus of Rs.330.26 lakhs arising out of it was credited to the revaluation reserve. 1994 - The Company entered into a marketing alliance with Colart Fine Art & Graphics Ltd. U.K. - The Company embarked upon a project for expanding manufacturing capacities of existing bulk drugs/chemical plant at Tarapur. - The Company undertook to set up a facility for manufacture of industrial grade synthetic adhesives at Taloja near Mumbai. - The Company issued Warrants to promoter group on preferential allotment basis. Of the 4,60,000 warrants, 3,32,000 warrants were converted into equity shares. - 3,32,100 equity shares allotted in conversion of warrants. 1995 - A major fire broke at Tarapur factory due to suspected electrical short circuit which led to destruction of godown, raw materials etc. - The Company initiated measures such as introduction of new products, change in product-mix, reduction in overheads and thrust on higher value addition. - 71,900 No. of Equity shares allotted in conversion of warrants. 1996 - 56,000 No. of Equity shares allotted in conversion of warrants. 1997 - The Joint Venture Agreement with M/s. A. W. Faber-Castell Gmbh & Co. Germany was terminated by both parties with effect from 30th November. - The company redeemed the last instalment of 33,340-14% Secured Redeemable Non-Convertible Debentures of Rs 100/- each issued in the year 1988. 2002 -Camlin Ltd has informed that Mr S D Dandekar, Executive Chairman of the Company, will be retiring from the Chairmanship of the Company. Mr D D Dandekar, Managing Director of the Company will be redesignated as "Chairman and Managing Director" w e f June 01, 2002. 2004 -Camlin Pharma, a division of Camlin Ltd, launched its mosquito repellent body spray, Repelmos, in the southern states -Delist from The Delhi Stock Exchange Association Ltd (DSE) with effect from December 11, 2004. 2005 -Camlin - JV with ColArt Fine Art & Graphics, U.K 2008 - The Company has splits its face value from Rs10/- to Rs1/-. 2011 -The Company have appointed M/s. Bigshare Services Private Limited having office at E/2,, Ansa Industrial Estate, Saki-Vihar Road, Sakinaka, Andheri (E), Mumbai - 400072 as Company's Registrar and Transfer Agents for the Company. 2012 -Company has changed its name from Camlin Ltd. to Kokuyo Camlin Ltd. 2013 -Kokuyo Camlin Ltd has ecided to issue Equity Shares on right basis in the ratio of 14 Equity Shares for every 29 Equity Shares held in the Company, of face value of Re. 1/- per Equity Share -Kokuyo Camlin Ltd has informed that the Company has received Rs. 10323.66 Lacs by way of allotment of Equity Shares on Rights basis. -Kokuyo Camlin has given Rights in the Ratio of 14 : 29 2014 -Directors has approved the appointment of Mr. Venkataraman Sriram as a Director. 2015 - Kokuyo Camlin to build state-of-the-art factory in Maharashtra. 2017 -Company has has started its Commercial Production/supply on 28th April, 2017

Read More

Parent Organisation

Kokuyo Camlin Ltd.

Founded

24/12/1946

Managing Director

Mr.Satish Veerappa

NSE Symbol

KOKUYOCMLNEQ

FAQ

The current price of Kokuyo Camlin Ltd is ₹ 118.97.

The 52-week high for Kokuyo Camlin Ltd is ₹ 120.13 and the 52-week low is ₹ 117.51.

The market capitalization of Kokuyo Camlin Ltd is currently ₹ 1193.31. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Kokuyo Camlin Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Kokuyo Camlin Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Kokuyo Camlin Ltd shares.

The CEO of Kokuyo Camlin Ltd is Mr.Satish Veerappa, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT